Levetiracetam Wockhardt

Levetiracetam, the active ingredient in Levetiracetam Wockhardt, is an anticonvulsant presented as an intravenous injection for intravenous use. It belongs to the pyrrolidine derivative class and is used to treat partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients who need rapid seizure control.

GNH USA supplies Levetiracetam Wockhardt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an anticonvulsant that acts on neuronal hyperexcitability in epilepsy. - Partial‑onset seizures: reduces seizure frequency and severity in patients with focal epilepsy. - Generalized tonic‑clonic seizures: helps achieve seizure control in patients with primary generalized epilepsy. - Myoclonic seizures: decreases occurrence of myoclonic jerks in appropriate patient populations.

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of lightheadedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate head pain. - Irritability: increased mood swings or agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood or behavior changes: depression, suicidal thoughts, or aggression. - Blood disorders: thrombocytopenia or neutropenia.

Levetiracetam requires careful consideration of patient‑specific factors and proper storage. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. - Pregnancy: safety not established; use only if benefits outweigh risks. - Psychiatric history: observe for worsening mood or behavioral changes. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with several medicines, necessitating monitoring or avoidance.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy. - Rifampin: induces metabolism leading to lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of central nervous system depression. - Opioids: additive sedative effects may occur. - Alcohol: can enhance dizziness and drowsiness.